BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6266042)

  • 1. [Seronegative systemic lupus erythematosus (author's transl)].
    Goff PL; Youinou P; Le Menn G
    Sem Hop; 1981 Jun 18-25; 57(25-28):1217-20. PubMed ID: 6266042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus].
    Manent-Ducreuzet C; Margulis J; Kahn MF
    Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):705-12. PubMed ID: 6975965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seronegative systemic lupus erythematosus.
    Bohan A
    J Rheumatol; 1979; 6(5):534-40. PubMed ID: 93147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus erythematosus latex tests compared with the immunofluorescence method for antinuclear factor.
    Chapman JC
    Am J Med Technol; 1976 May; 42(5):154-7. PubMed ID: 58558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disseminated lupus erythematosus without antinuclear antibodies or other autoantibodies].
    Duc J; Perroulaz G; Golaz J; Campiche M; Pécoud A
    Schweiz Med Wochenschr; 1987 Feb; 117(6):205-8. PubMed ID: 3494306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus with negative LE cells and antinuclear factor.
    Gladman DD; Chalmers A; Urowitz MB
    J Rheumatol; 1978; 5(2):142-7. PubMed ID: 78982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted criteria for the diagnosis of systemic lupus erythematosus.
    Clough JD; Elrazak M; Calabrese LH; Valenzuela R; Braun WB; Williams GW
    Arch Intern Med; 1984 Feb; 144(2):281-5. PubMed ID: 6421256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucocutaneous lesions in patients with systemic lupus erythematosus].
    Saurit V; Campana R; Ruiz Lascano A; Ducasse C; Bertoli A; Agüero S; Alvarellos A; Caeiro F
    Medicina (B Aires); 2003; 63(4):283-7. PubMed ID: 14518140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
    Al Attia HM
    Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seronegative leukocytoclastic vasculitis preceding the onset of disseminated systemic lupus erythematosus].
    Chevalier X; Belmatoug N; Kahn MF
    Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):779-83. PubMed ID: 2291068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of antinuclear antibody in lupus erythematosus (with cases report) (author's transl)].
    Shen JX
    Zhonghua Kou Qiang Ke Za Zhi; 1979 Jun; 14(2):101-3. PubMed ID: 318021
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoantibody determination in the diagnosis of systemic lupus erythematosus.
    Kurien BT; Scofield RH
    Scand J Immunol; 2006 Sep; 64(3):227-35. PubMed ID: 16918691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing patterns in the clinical features and prognosis of systemic lupus erythematosus - a Japanese experience.
    Hashimoto H; Shiokawa Y
    J Rheumatol; 1982; 9(3):386-9. PubMed ID: 7120233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive LE preps and negative ANA in brothers with SLE: is there still a role for the LE cell prep? A literature review.
    Wallace DJ; Metzger AL
    J Rheumatol; 1992 Mar; 19(3):497. PubMed ID: 1374474
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic lupus erythematosus in the elderly: clinical and serological characteristics.
    Catoggio LJ; Skinner RP; Smith G; Maddison PJ
    J Rheumatol; 1984 Apr; 11(2):175-81. PubMed ID: 6610051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
    van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN
    J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis.
    Blaustein DA; Blaustein SA
    J Rheumatol; 1998 Apr; 25(4):798-800. PubMed ID: 9558189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-DNA antibodies in systemic lupus erythematosus (author's transl)].
    Clotet B; Ruibal A; Pigrau C; Murcia C; Pahissa A; Lience E
    Med Clin (Barc); 1982 Feb; 78(4):128-131. PubMed ID: 6978438
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
    Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
    J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.